Catalyst Wire Dossier Catalyst Wire Dossier

ATORVALIQ

· CMP Pharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ATORVALIQ, covering 2023-02-01 to 2024-04-23. Get the full timeline:

Most recent: FDA Approved: ATORVALIQ — Supplemental Application (CMP Pharma, Inc.)

See pricing